ROHHAD syndrome is an extremely rare and life-threatening condition that affects children, causing a range of complex symptoms from rapid weight gain to breathing difficulties. While there is currently no cure, medical teams work to manage symptoms and improve quality of life through specialized care and monitoring, while researchers continue to search for better treatments and a deeper understanding of this puzzling disorder.

How doctors approach caring for children with ROHHAD

When a child receives a diagnosis of ROHHAD syndrome, families often face a reality that is both overwhelming and uncertain. This rare condition, which typically appears in previously healthy children between the ages of one and nine, requires a completely different approach to treatment than most other childhood illnesses. Rather than a single medication or procedure that can address the root cause, the medical care for ROHHAD focuses on managing each symptom as it appears and preventing life-threatening complications^[1].

The treatment journey for ROHHAD is highly individualized because every child experiences the condition differently. Some children develop severe breathing problems early on, while others may first struggle with hormone imbalances or difficulties with their autonomic nervous system—the part of the body that controls automatic functions like heart rate, temperature, and digestion. Because there is no standard protocol that works for all patients, healthcare providers must carefully observe each child and adjust care based on their specific needs^[2].

The goals of treatment are multifaceted. Medical teams aim to prevent dangerous breathing episodes that could lead to respiratory arrest, manage the rapid weight gain and metabolic changes, address hormone deficiencies that affect growth and development, and monitor for tumors that can develop in about half of all cases. Beyond physical symptoms, healthcare providers also work to support the behavioral and developmental challenges many children face, while helping families cope with the constant vigilance required to keep their child safe^[7].

Standard treatments currently used for ROHHAD syndrome

Because ROHHAD syndrome affects multiple body systems, treatment requires coordination among many different specialists. This typically includes experts in endocrinology (hormone disorders), pulmonology (lung and breathing disorders), cardiology (heart conditions), oncology (cancer and tumors), neurology (brain and nervous system), and sometimes psychiatry or psychology to address behavioral concerns. Children with ROHHAD are followed regularly by these teams at major medical centers, often requiring families to travel significant distances for specialized care^[1][2].

Managing breathing problems

The most critical aspect of ROHHAD treatment involves addressing hypoventilation, which means the body doesn’t breathe adequately on its own. Children with ROHHAD lose their normal automatic breathing response, meaning their brain doesn’t signal them to breathe faster or deeper when oxygen levels drop or carbon dioxide builds up. This is especially dangerous during sleep but can also occur while awake during physical activity or illness^[4].

Most children with ROHHAD eventually require mechanical ventilation support, particularly at night. This often involves a tracheostomy—a surgical opening in the neck through which a breathing tube is inserted—connected to a ventilator that breathes for the child during sleep. Some children may initially use non-invasive ventilation with masks, but many progress to needing the tracheostomy as their breathing becomes more severely impaired. The ventilator settings must be carefully adjusted and monitored regularly to ensure adequate oxygen levels and carbon dioxide removal^[14][17].

Children using ventilators at home require extensive family training and around-the-clock monitoring. Parents or nurses must be present at all times to suction the breathing tube, respond to equipment alarms, and watch for signs of respiratory distress. Backup power sources are essential since these life-saving devices depend on electricity. Many families must have emergency plans in place and cannot travel freely or participate in typical childhood activities without significant preparation^[17].

Before hypoventilation becomes severe, some children may undergo surgery to remove tonsils and adenoids if obstructive sleep apnea is present. This type of blockage often results from the obesity that characterizes ROHHAD, and removing these tissues can sometimes improve breathing in the short term. However, this does not address the underlying problem of the brain’s failure to regulate breathing properly^[4].

Addressing hormone imbalances

The hypothalamus is a small but crucial part of the brain that controls many hormone systems in the body. In ROHHAD syndrome, this region malfunctions, leading to various hormone deficiencies and imbalances. Treatment involves replacing these missing hormones or managing their effects through medication^[1].

Many children develop hypothyroidism, meaning their thyroid gland doesn’t produce enough thyroid hormone. This hormone is essential for growth, metabolism, and brain development. Doctors prescribe synthetic thyroid hormone (levothyroxine) that children take daily, with regular blood tests to ensure the dose is correct. Similarly, growth hormone deficiency is common and may be treated with growth hormone injections, though the rapid obesity characteristic of ROHHAD often complicates growth patterns^[7].

Diabetes insipidus is another frequent complication, though it’s different from the more common diabetes mellitus. In diabetes insipidus, the body cannot properly regulate water balance, leading to excessive urination and extreme thirst. If left untreated, this can cause dangerous changes in blood sodium levels. Treatment typically involves a medication called desmopressin, which replaces the missing hormone that normally helps the kidneys retain water. Families must carefully monitor fluid intake and output, and regular blood tests check sodium levels since both too-high and too-low sodium can cause serious problems including seizures^[4][14].

Children may also develop problems with puberty—either starting too early or too late—or have elevated prolactin levels. Each of these issues requires specific hormone treatments tailored to the individual child. The endocrinology team monitors these conditions closely through regular blood tests and adjusts medications as the child grows^[2].

Managing rapid weight gain and metabolism

The rapid-onset obesity that typically marks the beginning of ROHHAD is extremely challenging to address. Children may gain 20 to 30 pounds in just six to twelve months, and many develop hyperphagia, which means excessive, uncontrollable hunger. This weight gain is not simply due to overeating; it reflects a profound disruption in how the body regulates metabolism and energy balance^[4].

Treatment approaches include working with nutritionists to develop carefully controlled meal plans that provide adequate nutrition while attempting to limit further weight gain. However, families often report that despite strict dietary management and exercise programs, their children remain overweight or continue to gain weight. The metabolic dysfunction in ROHHAD appears to prevent normal weight loss, creating frustration and physical limitations for children who struggle with mobility and activity due to their size^[17].

Addressing autonomic nervous system dysfunction

The autonomic nervous system controls functions that happen automatically without conscious thought, such as heart rate, blood pressure, temperature regulation, sweating, digestion, and pain perception. When this system malfunctions in ROHHAD, children can experience a wide range of symptoms requiring different treatments^[1].

Some children develop bradycardia, an abnormally slow heart rate that may require medications or, in severe cases, a pacemaker to maintain an adequate heart rhythm. Others have problems with blood pressure regulation, experiencing dangerous drops or spikes that must be managed with medications. Temperature regulation problems mean children may become dangerously overheated or cold, requiring environmental controls and careful monitoring^[2].

Gastrointestinal problems are also common. Children may have severe constipation or diarrhea due to abnormal bowel motility. Treatment includes medications to regulate bowel movements, special diets, and in severe cases, surgical interventions to address motility issues. Some children have feeding difficulties and may require feeding tubes to ensure adequate nutrition^[7].

Altered pain perception presents another challenge. Some children feel little or no pain when they should, which means injuries or illnesses might go unnoticed. Others experience extreme pain from minor stimuli. Healthcare providers must carefully assess any complaints or lack thereof, knowing that typical pain responses cannot be relied upon^[18].

Monitoring and treating tumors

Approximately 40 to 50 percent of children with ROHHAD develop tumors derived from neural crest tissue, most commonly ganglioneuromas or ganglioneuroblastomas. These tumors typically develop in the chest or abdomen along the sympathetic nervous system chain. While these tumors are usually benign and slow-growing, they still require monitoring and sometimes surgical removal^[4][7].

Children undergo regular imaging studies—typically CT scans or MRIs—to screen for these tumors. The frequency of screening varies but often occurs annually or whenever new symptoms develop. If a tumor is found, an oncology team evaluates whether surgery is necessary. Successful tumor removal doesn’t cure ROHHAD or necessarily improve symptoms, but it eliminates a potential source of complications^[14].

Supporting behavioral and developmental needs

Many children with ROHHAD develop behavioral changes, mood disorders, or cognitive challenges. These may include aggression, emotional outbursts, difficulty with social interactions, developmental delays, or learning difficulties. Some children experience selective mutism or personality changes. These issues require evaluation by neuropsychology specialists and may be addressed through behavioral therapy, educational support, and sometimes psychiatric medications^[1][2].

Eye problems such as strabismus (crossed eyes) or pupil abnormalities also occur and require ophthalmology care. Some children need glasses or eye muscle surgery to correct vision problems^[4].

Experimental approaches being studied in clinical settings

The cause of ROHHAD syndrome remains unknown, making it difficult to develop targeted treatments. However, researchers have several theories about what might trigger the condition, and some experimental approaches are being tried based on these theories. It’s important to understand that these are not proven treatments and are being used on a case-by-case basis or studied in research settings^[1][7].

Autoimmune hypothesis and immunotherapy trials

One leading theory suggests that ROHHAD may be an autoimmune condition, meaning the body’s immune system mistakenly attacks its own tissues, particularly in the brain and nervous system. Some research has found antibodies and signs of inflammation in the cerebrospinal fluid of children with ROHHAD, supporting this possibility. If ROHHAD is indeed autoimmune, treatments that suppress the immune system might help slow or stop disease progression^[1][2].

Based on this theory, some children have been treated with immunosuppressive therapies. One documented case involved the use of rituximab, a medication that targets specific immune cells called B-cells. Rituximab is approved for treating certain autoimmune diseases and cancers, but its use in ROHHAD is experimental. Reports on children who received rituximab show variable results—some families and doctors report stabilization of symptoms or slight improvements, while others see no clear benefit. The medication requires intravenous infusion and carries risks of side effects including increased infection risk and infusion reactions^[12].

Another experimental approach reported in the medical literature involved high-dose chemotherapy with cyclophosphamide (also called Cytoxan). The idea behind this treatment was to “reboot” the immune system by temporarily suppressing it completely, then allowing it to rebuild without the abnormal attack on the body’s tissues. One child treated this way reportedly had no disease progression five years after treatment, though the symptoms present before chemotherapy remained. This is a very aggressive treatment with significant risks and is not standard care for ROHHAD^[14][15].

Researchers have also identified possible biomarkers—specific antibodies or proteins found in the blood or spinal fluid—that might help diagnose ROHHAD or predict which children might benefit from immunotherapy. Studies at institutions like Boston Children’s Hospital are working to identify these markers and understand whether they represent a cause of the disease or simply a result of it. These investigations are in early phases and have not yet led to proven treatments^[2][9].

Genetic and epigenetic research

Many researchers believe a genetic cause underlies ROHHAD syndrome, but despite extensive searching, no single gene mutation has been consistently identified in all patients. This is different from a related condition called congenital central hypoventilation syndrome, which is caused by mutations in a specific gene called PHOX2B. Children with ROHHAD do not have this mutation, which is one way doctors distinguish between the two conditions^[7].

Current genetic research includes projects collecting DNA samples from children with ROHHAD worldwide through international registries. Some studies are looking at the possibility that ROHHAD results from epigenetic changes—modifications in how genes are turned on or off rather than changes in the genetic code itself. Evidence for this comes from a reported case of identical twins where one developed ROHHAD and the other did not, suggesting environmental or epigenetic factors might play a role^[1].

Research groups are also investigating whether ROHHAD might be caused by autoantibodies targeting specific proteins in the hypothalamus or other parts of the nervous system. If such antibodies are identified and proven to cause the disease, treatments could potentially be developed to block or remove these antibodies. Clinical trials based on these findings have not yet begun, but this remains an active area of investigation^[10].

International research collaborations

Because ROHHAD is so rare—with fewer than 200 documented cases worldwide—international cooperation is essential for advancing research. The ROHHAD International Consortium brings together patient families, advocacy groups, clinicians, and researchers from multiple countries to share information, collect data through registries, and coordinate research efforts. These collaborations are funded primarily through charitable donations rather than pharmaceutical companies or government agencies, since ROHHAD is classified as an “orphan disease” that typically receives minimal research funding^[3].

Research projects currently underway include studies examining brain inflammation, hormone function, cellular models of hypothalamic dysfunction, and the relationship between tumors and the syndrome. Some of these studies are purely observational, collecting clinical information and biological samples to better understand the natural history of the disease. Others are exploring potential therapeutic targets at the molecular level^[19].

Major medical centers with expertise in ROHHAD include institutions in the United States (such as Children’s Hospital of Philadelphia, Boston Children’s Hospital, Johns Hopkins Hospital, Ann & Robert H. Lurie Children’s Hospital in Chicago), the United Kingdom (including Bristol Royal Hospital for Children and The Royal Hospital for Sick Children in Glasgow), and centers in other countries. Families often participate in research by allowing their children’s medical information and biological samples to be included in registries and studies, contributing to the collective knowledge about this condition^[10][21].

Clinical monitoring and surveillance studies

Some research efforts focus on better understanding how ROHHAD progresses and what factors might predict outcomes. These studies don’t test specific treatments but rather carefully document symptoms, laboratory findings, and disease course over time. For example, sleep studies, cardiac monitoring, specialized antibody tests, and advanced imaging help researchers characterize the full spectrum of the syndrome^[2].

In the United Kingdom, the British Paediatric Surveillance Unit has conducted surveillance studies to identify all cases of ROHHAD syndrome in the country and gather detailed clinical information. Similar efforts in other countries aim to determine the true incidence of ROHHAD and identify whether certain populations or geographic areas have higher rates of the condition. Such epidemiological data could provide clues about potential environmental or genetic risk factors^[10].

Most common treatment methods

• Mechanical ventilation support
  • Non-invasive ventilation using masks for breathing support during sleep, particularly in earlier stages of disease
  • Tracheostomy with home mechanical ventilator for children with severe hypoventilation requiring continuous or nighttime breathing support
  • Regular monitoring and adjustment of ventilator settings to maintain adequate oxygen and carbon dioxide levels
  • 24-hour supervision by trained family members or nurses to ensure equipment function and safety
• Hormone replacement therapy
  • Thyroid hormone replacement (levothyroxine) for hypothyroidism
  • Desmopressin medication for diabetes insipidus to regulate water balance
  • Growth hormone injections for growth hormone deficiency
  • Cortisol replacement for adrenal insufficiency when present
  • Medications to manage early or delayed puberty as needed
• Cardiac management
  • Medications to regulate abnormal heart rate patterns
  • Pacemaker implantation in cases of severe bradycardia that doesn’t respond to medication
  • Regular cardiac monitoring including Holter monitors and electrocardiograms
• Metabolic and nutritional management
  • Careful dietary planning with nutritionist consultation to limit further weight gain while ensuring adequate nutrition
  • Exercise programs adapted to the child’s physical limitations and breathing capacity
  • Management of salt and water intake to prevent dangerous sodium imbalances
• Tumor surveillance and treatment
  • Regular imaging studies (CT scans or MRIs) to screen for neural crest tumors
  • Surgical removal of ganglioneuromas or ganglioneuroblastomas when found
  • Ongoing oncology monitoring even after tumor removal
• Gastrointestinal symptom management
  • Medications to address severe constipation or diarrhea caused by autonomic dysfunction
  • Dietary modifications to manage motility problems
  • Feeding tube placement when oral intake is inadequate or unsafe
• Experimental immunotherapy
  • Rituximab infusions in select cases based on autoimmune hypothesis, with variable reported outcomes
  • High-dose cyclophosphamide chemotherapy in very limited cases as experimental immune system reset
  • These approaches are not standard treatment and carry significant risks
• Supportive care and monitoring
  • Regular multidisciplinary clinic visits coordinating endocrinology, pulmonology, cardiology, and other specialists
  • Sleep studies to assess breathing patterns and adjust ventilator settings
  • Frequent laboratory testing to monitor hormone levels and electrolyte balance
  • Behavioral therapy and educational support for developmental and emotional challenges
  • Ophthalmology care for eye abnormalities such as strabismus